PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Shyang Infomation Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Shyang’s Web-ADC® for Pharma Expand from RSS to Newsletter - The 12 sourced web-ADC® for Pharma’s RSS now expands to provide newsletter service for users without RSS reader
Shyang’s Web-ADC® for Pharma Expand from RSS to Newsletter

 

NewswireToday - /newswire/ - Taipei, Taiwan, 2006/09/07 - The 12 sourced web-ADC® for Pharma’s RSS now expands to provide newsletter service for users without RSS reader.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

To benefit users without an RSS reader, Shyang presents their newsletter service to complement the recently released web-ADC® for Pharma’s RSS. Now newsletter users can receive the same pharmaceutical news contents as the RSS users through e-mail.

Web-ADC® for Pharma’s RSS taps into 12 different news sites such as CNN, Reuters, Yahoo! and WebMD for pharmaceutical news. Then with statistical calculations of keywords, web-ADC® for Pharma’s RSS prioritizes the collected data to give the top ten news of the day, and delivers them to the RSS users. Yet with Shyang’s latest newsletter service, users without an RSS reader can receive the same content through e-mail as well.

According to a January 2006 survey done by the Consumer Federation of America, “get news” is the third most important function Internet users rated out of 17 categories, just after e-mail and product research. Web-ADC® for Pharma is Shyang’s new product that provides automatic and personalized pharmaceutical news and patents. By combining e-mail and news delivery, Shyang wishes to accommodate more Internet users with a special interest in pharmaceutical news.

For subscription and real-time update of the content of web-ADC® for Pharma News.

About Shyang Information Corporation

Shyang Information Corporation was founded in 1990 and provides automatic data collection (ADC) service. It latest product web-ADC® aims to globalize the collection of pharmaceutical information and is designed to deliver the latest pharmaceutical news and patent information. Recent new features include statistic analysis and topic map.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Shyang Infomation Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Shyang’s Web-ADC® for Pharma Expand from RSS to Newsletter

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Dharma Liu - Web-ADC.com 
+886 227956380 x144 dharma[.]web-ADC.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Shyang Infomation Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Shyang Infomation Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Persistence Market Research (P) Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)